Biotech Penny Stocks to Watch: Key Takeaways

  • Three winners from last week could offer even MORE trading opportunities.
  • High-volume spikers I’m watching for breakouts and breakdowns…
  • Insider buying, FDA approvals, and non-stop press releases are pumping these must-watch biotechs…

Click here to see why you don’t need a finance degree to be a successful trader

Check out the setup so good I HAD to come out of retirement … A high-volume breakout, with a catalyst, closing near its highs — I couldn’t ignore it. And even though I sold too soon, it was a $641 win.* See my trade details and what I’m watching for next below…

  1. Xeris Pharmaceuticals, Inc. (NASDAQ: XERS … Read our full analysis here.)
  2. Therapeutic Solutions International, Inc. (OTCPK: TSOI … Read our full analysis here.)
  3. Baudax Bio, Inc. (NASDAQ: BXRX … Read our full analysis here.)
  4. CASI Pharmaceuticals, Inc. (NASDAQ: CASI … Read our full analysis here.)
  5. Regen BioPharma, Inc. (OTCPK: RGBP … Read our full analysis here.)
  6. Adial Pharmaceuticals, Inc. (NASDAQ: ADIL … Read our full analysis here.)
  7. GeoVax Labs, Inc. (NASDAQ: GOVX … Read our full analysis here.)

Top Biotech Penny Stocks to Watch

These are the top stocks on my watchlist. ‘Watch’ is the key word here. There’s no guarantee that there’ll be a trading opportunity. Remember, these stocks move FAST.

Before we get to my list of stocks to watch, here are a few of my top resources for penny stocks…

How do I find hot stocks? I use StocksToTrade every day. For me, it’s the best tool because I helped design it specifically for trading penny stocks. (I’m also an investor.) It has awesome charts, built-in scans, social media feeds, and so much more to help you do your research.

And its Breaking News Chat add-on feature is a game-changer in this hot market. It helped me make record profits in 2020.* Get a StockToTrade 14-day trial for only $7

Or try it with the Breaking News Chat for only $17!

Now, let’s get to the top biotech penny stocks to watch this week…

Biotech Penny Stocks #1: Xeris Pharmaceuticals, Inc. (NASDAQ: XERS)

XERS develops ready-to-use injectable drugs.

The company announced the FDA approved its supplemental new drug application on August 23. XERS’s ready-to-use, single-dose liquid glucagon was approved for the treatment of severe hypoglycemia in diabetic patients over two years old.

The stock gapped up and traded almost 100 million in volume after the news. But it couldn’t hold its gains. It closed red and the next day it gapped down. I’ll watch it for a potential dip buy and bounce.

 

Biotech Penny Stocks #2: Therapeutic Solutions International, Inc. (OTCPK: TSOI)

Therapeutic Solutions develops therapies for a variety of diseases, as well as treatments for inflammation, aging, and sleep apnea.

It returns to the watchlist for the third straight week. I was watching for the breakout over 8 cents for two weeks. It finally broke out on August 19. (Past performance is not indicative of future results.) 

I bought it after it broke out and was holding up. My order was only partially filled. I bought 85,500 shares at $0.0875 before the close on August 19. I sold my position the next morning at $0.095 for a gain of $641.* Of course I sold too soon and the stock continued to run…

The company’s been pumping out PRs almost daily, which helped push the stock to run for multiple days.

But on August 24 the stock had its first red day. I bought the morning panic and again, I only got a partial fill on my order. I bought 75,600 shares at $0.112 and when the stock had a weak bounce, I sold at $0.114 for a small profit of $151.*

I’ll watch TSOI for an even bigger morning panic. Sometimes the bigger the panic, the bigger the bounce.

 

Biotech Penny Stocks #3: Baudax Bio, Inc. (NASDAQ: BXRX)

BXRX develops pain management injections for hospital and acute care use.

There’s no recent news on the company but SEC filings show the CFO bought 50,000 shares at 51 cents on August 20. On August 24 the stock gapped up over 25% on high volume but faded lower throughout the day.

I’ll watch for a dip buy into a big panic.

 

Biotech Penny Stocks #4: CASI Pharmaceuticals, Inc. (NASDAQ: CASI)

CASI develops multiple drugs to treat various diseases and cancer.

The stock gapped up and spiked on August 23 on high volume. It’s another company with no recent news but again, SEC filings show insider buying…

On August 18 the company chair and CEO bought 300,000 shares at $1.29 and another 180,000 shares at $1.26 on August 19.

Read the Form 4 here.

The stock’s consolidating after its big move. I’ll watch it for a news catalyst and high volume to create a potential breakout over $1.65. But this stock isn’t very volatile so I’ll swing for singles.

How do I find important company SEC filings? StocksToTrade makes it easy.* The built-in live news feed shows all the important stock news and SEC filings you need to know about. Start your StocksToTrade 14-day trial now for only $7.**

If you trade listed stocks, you MUST know how to read SEC filings. Learn how with my “Read SEC Filings” DVD here.

 

Biotech Penny Stocks #5: Regen BioPharma, Inc. (OTCPK: RGBP)

RGBP develops regenerative medical applications.

It’s another stock returning to the watchlist from last week. It was on watch for a breakout over $0.0335. It broke out on August 19 and ran for three days. (Past performance is not indicative of future results.)

Now it’s consolidating just below its recent high of 5 cents. I won’t chase it up here. I’ll watch it for a morning panic dip buy.

RGBP chart
RGBP YTD chart — courtesy StocksToTrade.com

Biotech Penny Stocks #6: Adial Pharmaceuticals, Inc. (NASDAQ: ADIL)

ADIL develops treatments for addiction and related disorders.

And yep, it’s another stock from last week’s watchlist. The company announced it would host a conference call on August 20 at 11 a.m. Eastern to discuss business developments and provide a clinical update. I was watching for a reaction after the conference call…

The stock had a green day on August 20 after the company announced it reached full enrollment for the Phase 3 trial of its treatment for alcohol use disorder. (Past performance is not indicative of future results.) 

That day, the stock hit resistance at $3.50. And it’s been consolidating under that level for a few days.

I’ll watch it for a potential breakout over $3.50, ideally with another catalyst and high volume.

 

Biotech Penny Stocks #7: GeoVax Labs, Inc. (NASDAQ: GOVX)

I’m cheating a bit with GOVX. It’s not technically a penny stock. But it was just last week…

Then the company’s chief scientific office presented study data on its COVID-19 vaccine at the European Society of Medicine General Assembly on August 19–21. The stock went from a closing price of $4.30 on August 19 to open at $7.43 on August 20.

But the stock couldn’t hold its gains and is now consolidating between $5 and $6. It’s a low float stock, so it could have a volatile move.

I’ll watch for it to choose a direction before planning a trade. A breakout over $6 could mean more potential upside. A breakdown below $5 could create a panic dip buy opportunity.

 

Get the List of Penny Stocks I’m Watching Delivered to Your Inbox

Want to know which stocks I’m watching each week? Subscribe to my no-cost watchlist. I’ll send my top penny stocks to watch right to your inbox every week. It can help you learn the process I follow for every stock.

penny stock checklist

I’ll say it again … The stocks on my watchlist aren’t an automatic buy. Remember to do your own due diligence and research. If you’re trading without a trading plan, you’re gambling. Don’t be a degenerate gambler — trade smart!

👉🏼 SUBSCRIBE to my no-cost weekly stock watchlist here.

Conclusion

Biotech penny stocks are stocks of small, developmental companies. These companies are usually desperate for cash. They need it to continue developing products and for testing and trials. Trade them with caution…

They’re known to be extremely volatile. They can have huge price swings. One minute they’re flying high on positive news — the next they’re down due to bad trial results, side effects, or stock dilution.

If you’re prepared to take advantage of the price swings, these stocks can offer great trading opportunities…

In my Trading Challenge chat room, my students and I talk about the hottest penny stocks. And many top traders who got their start in the Challenge are now chat moderators who answer questions and help out new students.

If you want to join a community of top traders, apply for my Trading Challenge. I don’t accept everyone. I only want the most dedicated students who are willing to put in the time and effort it takes to become my next top student. Could it be you?

What do you think of these biotech penny stocks to watch? Let me know in the comments … I love to hear from you!

Disclaimers

*Please note that these kinds of trading results are not typical and do not reflect the experience of the majority of individuals using our products. From January 1, 2020, to December 31, 2020, typical users of the products and services offered by this website reported earning, on average, an estimated $49.91 in profit. It takes years of dedication, hard work, and discipline to learn how to trade. Individual results will vary. Trading is inherently risky. Before making any trades, remember to do your due diligence and never risk more than you can afford to lose.

**Tim Sykes has a minority ownership stake in StockstoTrade.com.

The post Top Biotech Penny Stocks to Watch — August 25, 2021 appeared first on Timothy Sykes.

By